AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12869165 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine iontophoresis (2% lidocaine with 1:100,000 epinephrine)
Number of subjects: 60
Study 12869165 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 10674593 — intervention group
Group type: EXPERIMENTAL
Intervention: Meclizine (50 mg pretreatment)
Number of subjects: 343
Study 10674593 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 343
Study 10674593 — intervention group
Group type: COMPARATOR
Intervention: No drug (no pretreatment)
Number of subjects: 343
Study 9295240 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 423
Study 9295240 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 423
Study 8365603 — intervention group
Group type: EXPERIMENTAL
Intervention: 105-cm polyurethane feeding tubes
Number of subjects: 45
Study 8365603 — intervention group
Group type: EXPERIMENTAL
Intervention: 125-cm polyurethane feeding tubes
Number of subjects: 45
Study 8365603 — intervention group
Group type: EXPERIMENTAL
Intervention: 145-cm polyurethane feeding tubes
Number of subjects: 45
Study 8365603 — intervention group
Group type: EXPERIMENTAL
Intervention: All tube lengths
Number of subjects: 45
Study 2821397 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous CMV immune globulin
Number of subjects: 59
Study 2821397 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 59
Study 31963773 — intervention group
Group type: EXPERIMENTAL
Intervention: NAT-FM+TAU
Number of subjects: 160
Study 31963773 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 160
Study 29242937 — intervention group
Group type: EXPERIMENTAL
Intervention: Pazopanib plus paclitaxel
Number of subjects: 106
Study 29242937 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel alone
Number of subjects: 106
Study 27522394 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily fixed combination (ODFC) of perindopril 10mg, indapamide 2.5mg, amlodipine 5 or 10mg, and atorvastatin 20mg
Number of subjects: 305
Study 27522394 — intervention group
Group type: COMPARATOR
Intervention: Free-drug combination (FDC) of the 3 antihypertensive agents plus atorvastatin 20mg
Number of subjects: 305
Study 26635011 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy
Number of subjects: 30
Study 26635011 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 30
Study 23557931 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal exposure to mycophenolic acid (MPA)
Number of subjects: 490
Study 20964767 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 ml·kg(‐1) of local anesthetic solution
Number of subjects: 45
Study 20964767 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 ml·kg(‐1) of local anesthetic solution
Number of subjects: 45
Study 20964767 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 ml·kg(‐1) of local anesthetic solution
Number of subjects: 45
Study 17935144 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive-expressive group therapy
Number of subjects: 353
Study 17935144 — intervention group
Group type: COMPARATOR
Intervention: Education control condition
Number of subjects: 353
Study 21679304 — intervention group
Group type: EXPERIMENTAL
Intervention: Vardenafil 10 mg (titrated to 20 or 5 mg after 4 weeks)
Number of subjects: 343
Study 21679304 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 343
Study 16194647 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Nurse Specialist (CNS)
Number of subjects: 620
Study 16194647 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 620
Study 11883964 — intervention group
Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation of the mandibular condyle
Number of subjects: 54
Study 9883917 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands poised method
Number of subjects: 5471
Study 9883917 — intervention group
Group type: COMPARATOR
Intervention: Hands on method
Number of subjects: 5471
Study 8039534 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole (100 mg capsule) after a full meal
Number of subjects: 24
Study 8039534 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (100 mg capsule) after a full meal
Number of subjects: 24
Study 8039534 — intervention group
Group type: COMPARATOR
Intervention: Itraconazole (100 mg capsule) on an empty stomach
Number of subjects: 24
Study 8039534 — intervention group
Group type: COMPARATOR
Intervention: Itraconazole (100 mg capsule) after a light meal
Number of subjects: 24
Study 8039534 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole (100 mg capsule) on an empty stomach
Number of subjects: 24
Study 8039534 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole (100 mg capsule) after a light meal
Number of subjects: 24
Study 3043994 — intervention group
Group type: EXPERIMENTAL
Intervention: Indobufen 200 mg b.i.d.
Number of subjects: 42
Study 3043994 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 30115530 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical pirfenidone
Number of subjects: 24
Study 30115530 — intervention group
Group type: COMPARATOR
Intervention: Non-adherent gauze (Control)
Number of subjects: 24
Study 26720746 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine deployment at all hospitals
Number of subjects: 121
Study 26720746 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine deployment at outer-ring hospitals only
Number of subjects: 121
Study 26720746 — intervention group
Group type: EXPERIMENTAL
Intervention: No telemedicine deployment
Number of subjects: 121
Study 26720746 — intervention group
Group type: EXPERIMENTAL
Intervention: Central physician location with partial telemedicine deployment
Number of subjects: 121
Study 25515056 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma Exchange (PE)
Number of subjects: 64
Study 25515056 — intervention group
Group type: COMPARATOR
Intervention: Intravenous Immunoglobulin (IVIg)
Number of subjects: 64
Study 23565835 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief health education counselling from nurses, a health education booklet, a 'no smoking' sticker, and a telephone reminder one week later.
Number of subjects: 1483
Study 23565835 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 1483
Study 20538692 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous MgSO4 infusion (80 mmol in 500 mL normal saline per day)
Number of subjects: 0
Study 20538692 — intervention group
Group type: COMPARATOR
Intervention: Placebo (500 mL normal saline per day)
Number of subjects: 0
Study 19001531 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care (intensified structured counseling between patient and pharmacist)
Number of subjects: 410
Study 19001531 — intervention group
Group type: COMPARATOR
Intervention: Standard counseling (control group)
Number of subjects: 410
Study 19001531 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care (intervention group)
Number of subjects: 410
Study 16946665 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment preference among White patients (55%)
Number of subjects: 2323
Study 16946665 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment preference among White patients (46%)
Number of subjects: 2323
Study 16946665 — intervention group
Group type: COMPARATOR
Intervention: Randomization rates among Black IDH patients (46%)
Number of subjects: 2323
Study 16946665 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment preference (unsure) for IDH patients
Number of subjects: 2323
Study 16946665 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment preference (surgical) for IDH patients
Number of subjects: 2323
Study 16946665 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment preference (unsure) for SpS/DS patients
Number of subjects: 2323
Study 16946665 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment preference (surgical) for SpS/DS patients
Number of subjects: 2323
Study 14557432 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vitamin D (500 IU)
Number of subjects: 22
Study 14557432 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose vitamin D (200 IU)
Number of subjects: 22
Study 14557432 — intervention group
Group type: COMPARATOR
Intervention: Prolonged critical illness (compared to matched controls)
Number of subjects: 22
Study 14557432 — intervention group
Group type: EXPERIMENTAL
Intervention: Time in intensive care
Number of subjects: 22
Study 10750207 — intervention group
Group type: EXPERIMENTAL
Intervention: Training alone
Number of subjects: 84
Study 10750207 — intervention group
Group type: EXPERIMENTAL
Intervention: Training plus ongoing telephone support
Number of subjects: 84
Study 10750207 — intervention group
Group type: COMPARATOR
Intervention: Control (no training or support)
Number of subjects: 84
Study 9016145 — intervention group
Group type: EXPERIMENTAL
Intervention: Rinsing enteral delivery sets with tap water before formula addition
Number of subjects: 23
Study 9016145 — intervention group
Group type: COMPARATOR
Intervention: No rinsing of enteral delivery sets before formula addition
Number of subjects: 23
Study 2028125 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-parametric estimator of prevalence of chronic graft-versus-host disease
Number of subjects: 0
Study 2028125 — intervention group
Group type: COMPARATOR
Intervention: Markov and semi-Markov models
Number of subjects: 0
Study 6424228 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-lactose milk (500 ml)
Number of subjects: 35
Study 6424228 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-lactose milk (250 ml)
Number of subjects: 35
Study 6424228 — intervention group
Group type: COMPARATOR
Intervention: Regular skim milk
Number of subjects: 35
Study 29992524 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT)
Number of subjects: 121
Study 29992524 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline late HMR
Number of subjects: 121
Study 29992524 — intervention group
Group type: EXPERIMENTAL
Intervention: 123I‐mIBG imaging
Number of subjects: 121
Study 29992524 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvement in late HMR
Number of subjects: 121
Study 29500103 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral discectomy
Number of subjects: 9
Study 29500103 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral discopexy
Number of subjects: 9
Study 29500103 — intervention group
Group type: COMPARATOR
Intervention: Sham surgery
Number of subjects: 9
Study 27010626 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical reconstruction of facial defects
Number of subjects: 200
Study 27010626 — intervention group
Group type: EXPERIMENTAL
Intervention: Repair of a de novo small peripheral defect
Number of subjects: 200
Study 27010626 — intervention group
Group type: EXPERIMENTAL
Intervention: Repair of a large defect
Number of subjects: 200
Study 27010626 — intervention group
Group type: EXPERIMENTAL
Intervention: Repair of a central defect
Number of subjects: 200
Study 27010626 — intervention group
Group type: EXPERIMENTAL
Intervention: Willingness to pay per quality-adjusted life-year (WTP/QALY) for small peripheral defects
Number of subjects: 200
Study 27010626 — intervention group
Group type: EXPERIMENTAL
Intervention: Willingness to pay per quality-adjusted life-year (WTP/QALY) for large central defects
Number of subjects: 200
Study 24068617 — intervention group
Group type: EXPERIMENTAL
Intervention: Lapband®
Number of subjects: 180
Study 24068617 — intervention group
Group type: COMPARATOR
Intervention: SAGB®
Number of subjects: 180
Study 22209175 — intervention group
Group type: EXPERIMENTAL
Intervention: Head down at 10° first and then 10° up and tilted right laterally during PAC placement (study group)
Number of subjects: 140
Study 22209175 — intervention group
Group type: COMPARATOR
Intervention: Supine position during pulmonary artery catheterization (control group)
Number of subjects: 140
Study 22209175 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (study and control)
Number of subjects: 140
Study 19444821 — intervention group
Group type: EXPERIMENTAL
Intervention: CYSTUS052 lozenges
Number of subjects: 300
Study 19444821 — intervention group
Group type: COMPARATOR
Intervention: Green tea extract
Number of subjects: 300
Study 18971153 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa
Number of subjects: 45
Study 18971153 — intervention group
Group type: COMPARATOR
Intervention: Recombinant human erythropoietin (r‐HuEPO)
Number of subjects: 45
Study 15855656 — intervention group
Group type: EXPERIMENTAL
Intervention: l-homocysteine (65.1 micromol/kg body wt)
Number of subjects: 14
Study 15855656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 15514571 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents
Number of subjects: 0
Study 15514571 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents
Number of subjects: 0
Study 15514571 — intervention group
Group type: COMPARATOR
Intervention: Bare metal stents
Number of subjects: 0
Study 11406741 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion SR
Number of subjects: 450
Study 11406741 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 450
Study 9262275 — intervention group
Group type: COMPARATOR
Intervention: Long-term pituitary desensitization followed by gonadotrophin therapy, oocyte retrieval and embryo transfer (group 1)
Number of subjects: 50
Study 9262275 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic ovarian electrocautery after pituitary desensitization followed by gonadotrophin therapy, oocyte retrieval and embryo transfer (group 2)
Number of subjects: 50
Study 8328096 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream (25 mg lidocaine and 25 mg prilocaine per gram of cream)
Number of subjects: 118
Study 8328096 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study 8328096 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 118
Study 3555030 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (750 mg twice daily)
Number of subjects: 87
Study 3555030 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 87
Study 3555030 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin (500 mg four times daily)
Number of subjects: 87
Study 29329587 — intervention group
Group type: EXPERIMENTAL
Intervention: Web 2.0 intervention
Number of subjects: 504
Study 29329587 — intervention group
Group type: COMPARATOR
Intervention: Web 1.0 intervention
Number of subjects: 504
Study 29329587 — intervention group
Group type: COMPARATOR
Intervention: Logbook intervention
Number of subjects: 504
Study 26547399 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC) (30-45 seconds)
Number of subjects: 208
Study 26547399 — intervention group
Group type: COMPARATOR
Intervention: Immediate cord clamping (ICC) (<10 seconds)
Number of subjects: 208
Study 24622429 — intervention group
Group type: EXPERIMENTAL
Intervention: FIREHAWK stent
Number of subjects: 730
Study 23778526 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated neutrophil counts
Number of subjects: 362
Study 23778526 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated platelet counts
Number of subjects: 362
Study 23778526 — intervention group
Group type: EXPERIMENTAL
Intervention: High neutrophil-lymphocyte ratio
Number of subjects: 362
Study 23778526 — intervention group
Group type: EXPERIMENTAL
Intervention: New prognostic classification incorporating inflammatory markers
Number of subjects: 362
Study 20489194 — intervention group
Group type: EXPERIMENTAL
Intervention: Emerging therapeutic modalities targeting various mechanisms for neuropathic pain
Number of subjects: 0
Study 20489194 — intervention group
Group type: EXPERIMENTAL
Intervention: Unbiased evaluation of neurobiological mechanisms in individual patients
Number of subjects: 0
Study 20489194 — intervention group
Group type: EXPERIMENTAL
Intervention: Genomewide association studies and discovery science approaches
Number of subjects: 0
Study 20489194 — intervention group
Group type: EXPERIMENTAL
Intervention: Development of sophisticated tools for measuring neuropathic pain
Number of subjects: 0
Study 18983546 — intervention group
Group type: EXPERIMENTAL
Intervention: Tecnis Z9001 IOLs
Number of subjects: 196
Study 18983546 — intervention group
Group type: EXPERIMENTAL
Intervention: Akreos AO IOLs
Number of subjects: 196
Study 18983546 — intervention group
Group type: COMPARATOR
Intervention: KS-1 IOLs
Number of subjects: 196
Study 16651950 — intervention group
Group type: EXPERIMENTAL
Intervention: Barbed suture
Number of subjects: 188
Study 16651950 — intervention group
Group type: COMPARATOR
Intervention: Conventional closure using 3-0 polydioxanone suture
Number of subjects: 188
Study 12816290 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser (ERL) using an energy level of 160 mJ/pulse and 10 Hz
Number of subjects: 20
Study 12816290 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) using hand instruments
Number of subjects: 20
Study 12816290 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (ERL and SRP)
Number of subjects: 20
Study 12816290 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical analysis between ERL and SRP
Number of subjects: 20
Study 10092259 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg twice daily, amoxicillin 1000 mg twice daily, and clarithromycin 500 mg twice daily for 7 days
Number of subjects: 278
Study 10092259 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 7 days
Number of subjects: 278
Study 10092259 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment and placebo groups
Number of subjects: 278
Study 7762516 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone treatment for 6 months
Number of subjects: 0
Study 7762516 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7762516 — intervention group
Group type: COMPARATOR
Intervention: Total Body Potassium (TBK)
Number of subjects: 0
Study 7762516 — intervention group
Group type: COMPARATOR
Intervention: Bioelectrical Impedance Analysis (BIA)
Number of subjects: 0
Study 7762516 — intervention group
Group type: COMPARATOR
Intervention: Dual-energy X-ray absorptiometry (DXA)
Number of subjects: 0
Study 2102716 — intervention group
Group type: COMPARATOR
Intervention: 40 mg/iv of metoclopramide (Group A)
Number of subjects: 56
Study 2102716 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg iv of metoclopramide and 125 mg/iv of methylprednisolone (Group B)
Number of subjects: 56
Study 2102716 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/oral of lorazepam, 125 mg/iv methylprednisolone, and 1 mg/kg/oral of metoclopramide (Group C)
Number of subjects: 56
Study 365151 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine (Marcaine), lidocaine (Xylocaine), and epinephrine mixture
Number of subjects: 126
Study 365151 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine and epinephrine
Number of subjects: 126
Study 29462104 — intervention group
Group type: EXPERIMENTAL
Intervention: QuantiFERON-TB Gold
Number of subjects: 0
Study 27124889 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (TU)
Number of subjects: 199
Study 27124889 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study 24952938 — intervention group
Group type: EXPERIMENTAL
Intervention: DASS-12 (12-item Depression, Anxiety and Stress Scale)
Number of subjects: 2850
Study 24952938 — intervention group
Group type: COMPARATOR
Intervention: DASS-21 (21-item Depression, Anxiety and Stress Scale)
Number of subjects: 2850
Study 22943928 — intervention group
Group type: EXPERIMENTAL
Intervention: Micafungin at therapeutic dose (300 mg/body)
Number of subjects: 15
Study 22943928 — intervention group
Group type: COMPARATOR
Intervention: Micafungin at prophylactic dose (150 mg/body)
Number of subjects: 15
Study 22943928 — intervention group
Group type: COMPARATOR
Intervention: Micafungin at lower prophylactic dose (50 mg/body)
Number of subjects: 15
Study 20823760 — intervention group
Group type: EXPERIMENTAL
Intervention: NAVA
Number of subjects: 15
Study 20823760 — intervention group
Group type: COMPARATOR
Intervention: PSV
Number of subjects: 15
Study 18436564 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 polyunsaturated fatty acids (PUFA)
Number of subjects: 206
Study 18436564 — intervention group
Group type: COMPARATOR
Intervention: Control treatment (olive oil)
Number of subjects: 206
Study 16023303 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime continuous infusion (60 mg/kg/day following a 20 mg/kg loading dose)
Number of subjects: 16
Study 16023303 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime intermittent administration (20 mg/kg every 8 hours)
Number of subjects: 16
Study 14665488 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin plus pyrazinamide (2RZ)
Number of subjects: 76
Study 14665488 — intervention group
Group type: COMPARATOR
Intervention: Isoniazid (6H)
Number of subjects: 76
Study 10348466 — intervention group
Group type: EXPERIMENTAL
Intervention: L-dopa/carbidopa (750 mg per day)
Number of subjects: 16
Study 10348466 — intervention group
Group type: EXPERIMENTAL
Intervention: L-selegiline (10 mg per day)
Number of subjects: 16
Study 8611072 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated estrogens (CE) 50 mg
Number of subjects: 0
Study 8611072 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh-frozen plasma (FFP) 2 U
Number of subjects: 0
Study 8611072 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 2157983 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized amiloride (5 mmol per liter; 3.5 ml four times daily)
Number of subjects: 14
Study 2157983 — intervention group
Group type: COMPARATOR
Intervention: Vehicle alone (control)
Number of subjects: 14
Study 2157983 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized amiloride
Number of subjects: 14
Study 7241678 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative techniques with no dissection or excision of the parietal vaginalis
Number of subjects: 87
Study 7241678 — intervention group
Group type: COMPARATOR
Intervention: Other hydrocelectomy techniques (dissection or excision of the parietal vaginalis)
Number of subjects: 87
Study 6368246 — intervention group
Group type: EXPERIMENTAL
Intervention: azimexon (3 X 600 mg) added to chemotherapy
Number of subjects: 14
Study 31305326 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk containing only A2 β-casein
Number of subjects: 0